Over the last 7 days, the Pharma industry has risen 5.5%, driven by gains from Yuhan of 2.0%. This takes the industry's 12 month performance to a gain of 8.1%. Earnings are forecast to grow by 34% annually.
Has the South Korean Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 26 Apr 2024 | ₩50.8t | ₩29.4t | ₩922.9b | 16.5x | 55x | 1.7x |
Sun, 24 Mar 2024 | ₩55.5t | ₩30.1t | ₩890.9b | 21.4x | 62.3x | 1.8x |
Tue, 20 Feb 2024 | ₩52.2t | ₩29.6t | ₩593.1b | 21.1x | 88x | 1.8x |
Thu, 18 Jan 2024 | ₩51.8t | ₩29.6t | ₩592.3b | 22.4x | 87.5x | 1.8x |
Sat, 16 Dec 2023 | ₩50.6t | ₩29.6t | ₩588.2b | 21.5x | 86x | 1.7x |
Mon, 13 Nov 2023 | ₩48.3t | ₩29.3t | ₩683.4b | 16.7x | 70.7x | 1.6x |
Wed, 11 Oct 2023 | ₩50.4t | ₩29.3t | ₩683.3b | 17.1x | 73.7x | 1.7x |
Fri, 08 Sep 2023 | ₩50.1t | ₩29.3t | ₩683.9b | 15.9x | 73.3x | 1.7x |
Sun, 06 Aug 2023 | ₩51.8t | ₩28.8t | ₩884.1b | 22.2x | 58.6x | 1.8x |
Tue, 04 Jul 2023 | ₩47.5t | ₩28.8t | ₩899.2b | 20.7x | 52.8x | 1.6x |
Thu, 01 Jun 2023 | ₩47.5t | ₩28.9t | ₩904.9b | 22.9x | 52.5x | 1.6x |
Sat, 29 Apr 2023 | ₩47.7t | ₩28.5t | ₩602.7b | 20.9x | 79.1x | 1.7x |
Mon, 27 Mar 2023 | ₩44.1t | ₩28.3t | ₩655.8b | 21.6x | 67.2x | 1.6x |
Wed, 22 Feb 2023 | ₩45.5t | ₩27.7t | ₩743.5b | 20.6x | 61.1x | 1.6x |
Fri, 20 Jan 2023 | ₩44.9t | ₩28.0t | ₩770.2b | 19.7x | 58.3x | 1.6x |
Sun, 18 Dec 2022 | ₩47.7t | ₩28.0t | ₩770.2b | 20.1x | 61.9x | 1.7x |
Tue, 15 Nov 2022 | ₩45.0t | ₩27.3t | ₩701.8b | 21x | 64.1x | 1.6x |
Thu, 13 Oct 2022 | ₩40.4t | ₩27.2t | ₩694.8b | 19.9x | 58.1x | 1.5x |
Sat, 10 Sep 2022 | ₩47.6t | ₩27.5t | ₩725.5b | 21.8x | 65.6x | 1.7x |
Mon, 08 Aug 2022 | ₩52.5t | ₩26.7t | ₩475.9b | 23.6x | 110.2x | 2x |
Wed, 06 Jul 2022 | ₩48.6t | ₩26.7t | ₩475.9b | 20.5x | 102.2x | 1.8x |
Fri, 03 Jun 2022 | ₩54.2t | ₩26.7t | ₩468.1b | 24.5x | 115.8x | 2x |
Sun, 01 May 2022 | ₩57.0t | ₩26.1t | ₩674.3b | 27.3x | 84.5x | 2.2x |
Tue, 29 Mar 2022 | ₩56.6t | ₩25.9t | ₩739.5b | 25x | 76.6x | 2.2x |
Thu, 24 Feb 2022 | ₩53.1t | ₩25.0t | ₩934.5b | 23.4x | 56.8x | 2.1x |
Sat, 22 Jan 2022 | ₩54.0t | ₩25.0t | ₩934.5b | 22.4x | 57.8x | 2.2x |
Mon, 20 Dec 2021 | ₩61.8t | ₩25.0t | ₩934.5b | 26.1x | 66.1x | 2.5x |
Wed, 17 Nov 2021 | ₩61.7t | ₩24.7t | ₩872.6b | 27.8x | 70.7x | 2.5x |
Fri, 15 Oct 2021 | ₩64.1t | ₩24.7t | ₩876.1b | 24.7x | 73.2x | 2.6x |
Sun, 12 Sep 2021 | ₩71.1t | ₩26.0t | ₩960.6b | 38.4x | 74.1x | 2.7x |
Tue, 10 Aug 2021 | ₩72.4t | ₩26.0t | ₩960.3b | 40.6x | 75.4x | 2.8x |
Mon, 03 May 2021 | ₩69.3t | ₩24.9t | ₩915.5b | 34.8x | 75.7x | 2.8x |
75.7x
How does South Korean Pharma compare with similar industries?
KR Market | -0.36% | |
Healthcare | 0.63% | |
Pharma | 0.52% | |
Pharma | 0.52% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
A009420 Hanall Biopharma | ₩34.75k | 8.3% +₩134.3b | 69.5% | PE502.1x | |
A000100 Yuhan | ₩71.00k | 2.5% +₩127.0b | 29.4% | PE39x | |
A008930 Hanmi Science | ₩33.35k | 4.2% +₩91.5b | -23.9% | PE19.6x | |
A039200 Oscotec | ₩30.20k | 7.7% +₩82.1b | 42.5% | PS233x | |
A140410 Mezzion PharmaLtd | ₩38.25k | 6.3% +₩66.8b | 75.5% | PS35.8x |